Vanberra Signal

ConcertAI

Curated by Signal

AI-based platform for oncology research and data

Overview

AI-based platform for oncology research and data. The data it provides are lab results, oncology practice visits, tumor-related observations, vitals, biometric pain, medications, and diagnosis state. It also provides budgets, costs, comorbidities, and others. It offers real-time matching of patients to clinical trials and collaborates with biopharma science companies.

Key facts

Founded
2002

Business model

Contact

Open roles

40 roles
  • Territory Sales Manager

    Miami, FL · On-site · Internship

  • Senior Client Success Partner

    Greater Philadelphia · On-site · Internship

  • Product Manager, Cadence Suite

    Greater Philadelphia · On-site · Internship

+ 37 more open roles on Signal

More on Vanberra Signal

Members only

Competitors & similar companies

More Health Technology companies
  • Provider of an online doctor consultation platform for childcare

    Health TechnologyUnited States
  • Provider of integrated digital system solution services

    Health TechnologySt. Louis Park, United States
  • Digital EHR and communication management system for providers

    Health TechnologyChicago, United States

About ConcertAI

What does ConcertAI do?

AI-based platform for oncology research and data.

Where is ConcertAI headquartered?

ConcertAI is headquartered in Boston, United States.

When was ConcertAI founded?

ConcertAI was founded in 2002.

Which sector is ConcertAI in?

ConcertAI operates in Health Technology.

Who are ConcertAI's competitors?

Companies similar to ConcertAI include Napp Networks, HealtheMed, and Mobile MediClaim.

Is ConcertAI hiring?

Yes. ConcertAI has 40 open roles listed on Vanberra Signal.